Guardant Health
Liquid biopsy tests that detect circulating tumor DNA in blood samples for cancer diagnosis, monitoring, and treatment selection
- Sector
- Biotech
- Headquarters
- Redwood City, CA
- Founded
- 2011
- Latest Form D
- $320M, Aug 2017
- Total capital
- $500M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $500M
- 5 Form D · last Aug 2017
- 111 months since last filing
- Federal contracts
- $14K
- 2 awards · Veterans Affairs, Health and Human S
- Rank in Biotech#376 of 4373
- Granted patents
- 16
- 24 pending · first 2026
- Rank in peer group#1 of 342
Capital timeline
Latest events
- Federal contractHealth and Human S · Laboratory Testing$14K
- Private capital raisedForm D · SEC · 5th filing$320M
- Private capital raisedForm D · SEC · 4th filing$82.8M
- Private capital raisedForm D · SEC · 3rd filing$56M
- Private capital raisedForm D · SEC · 2nd filing$31.5M
- Private capital raisedForm D · SEC · 1st filing$9.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#1 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Aaref HilalyDirectorNamed in SEC Form D filings
- AmirAli TalasazExecutive Officer, DirectorNamed in SEC Form D filings
- Helmy EltoukhyExecutive Officer, DirectorNamed in SEC Form D filings
- Michael WileyExecutive OfficerNamed in SEC Form D filings
- Samir KaulDirectorNamed in SEC Form D filings
- Samir KaurDirectorNamed in SEC Form D filings
Show all 7 people
- Warren HogarthDirectorNamed in SEC Form D filings
What it has protected
USPTO · 16 granted of 40- New patentMicrosatellite Instability Detection In Cell-free DnaUSPTOUS 12,767,991
- New patentMethods For Fragmentome Profiling Of Cell-free Nucleic AcidsUSPTOUS 12,770,714
- New patentMethods And Systems For Detecting Genetic VariantsUSPTOUS 12,767,980
Show all 40 patent records
- Microsatellite Instability Detection In Cell-free DnaOct 20, 2026 · US 12,767,991Granted
- Methods For Fragmentome Profiling Of Cell-free Nucleic AcidsOct 20, 2026 · US 12,770,714Granted
- Methods And Systems For Detecting Genetic VariantsOct 20, 2026 · US 12,767,980Granted
- Predictive Model For Determining Changes In Molecular StateSep 22, 2026 · US 12,744,128Granted
- Sequencing Methods With PartitioningSep 22, 2026 · US 12,742,204Granted
- Tumor Fraction And Outcome Association In A Real-world Non-small Cell Lung Cancer (nsclc) Cohort Using A Methylation-based Circulating Tumor Dna (ctdna) AssaySep 17, 2026 · Application 19678042Pending
- Compositions And Methods For Isolating Cell-free DnaSep 17, 2026 · Application 19679220Pending
- Systems And Methods To Detect Rare Mutations And Copy Number VariationSep 15, 2026 · US 12,735,751Granted
- Methods And Compositions For Anchored Multiplex Ngs WorkflowsSep 10, 2026 · Application 19277876Pending
- Computer Architecture For Identifying Lines Of TherapySep 3, 2026 · Application 19449032Pending
- Methods For Early Detection Of CancerAug 27, 2026 · Application 19646143Pending
- Microsatellite Instability Detection In Cell-free DnaAug 25, 2026 · US 12,716,102Granted
- Microsatellite Instability Detection In Cell-free DnaAug 25, 2026 · US 12,716,103Granted
- Methods And Applications Of Gene Fusion Detection In Cell-free Dna AnalysisAug 20, 2026 · Application 19646161Pending
- Methods For Detecting Nucleic Acid Variants Using Capture ProbesAug 20, 2026 · Application 19655285Pending
- Methods For Detecting Nucleic Acid VariantsAug 13, 2026 · Application 19655248Pending
- Methods For Early Detection Of CancerAug 13, 2026 · Application 19637857Pending
- Detecting Tumor-related Information Based On Methylation Status Of Cell-free Nucleic Acid MoleculesAug 13, 2026 · Application 19637404Pending
- Population Based Treatment Recommender Using Cell Free DnaAug 11, 2026 · US 12,706,179Granted
- Population Based Treatment Recommender Using Cell Free DnaAug 11, 2026 · US 12,706,178Granted
- Use Of Cell Free Bacterial Nucleic Acids For Detection Of CancerJul 30, 2026 · Application 19375062Pending
- Microsatellite Instability Detection In Cell-free DnaJul 28, 2026 · US 12,692,552Granted
- Methods For Analysis Of Dna MethylationJul 23, 2026 · Application 19371623Pending
- Quality Control Method For Enzymatic Conversion ProceduresJul 23, 2026 · Application 19371162Pending
- Database For Therapeutic InterventionsJun 25, 2026 · Application 19540253Pending
- Systems And Methods To Detect Rare Mutations And Copy Number VariationJun 23, 2026 · US 12,662,697Granted
- Computational Modeling Of Loss Of Function Based On Allelic FrequencyJun 23, 2026 · US 12,665,050Granted
- Compositions And Methods For Analyzing Cell-free Dna In Methylation Partitioning AssaysJun 16, 2026 · US 12,655,469Granted
- Methylated Enrichment Methods For Single-molecule Genetic And Epigenetic SequencingJun 11, 2026 · Application 19535178Pending
- Direct Methylation Single-base Resolution Sequencing Of Enriched Unmethylated DnaJun 11, 2026 · Application 19276680Pending
- Methods To Enrich Nucleotide Variants By Negative SelectionMay 28, 2026 · Application 19461369Pending
- Classification Of Breast Tumors Using Dna Methylation From Liquid BiopsyMay 21, 2026 · Application 19446788Pending
- Classification Of Colorectal Tumors Using Dna Methylation From Liquid BiopsyMay 21, 2026 · Application 19446794Pending
- Compositions And Methods For Isolating Cell-free DnaMay 19, 2026 · US 12,630,882Granted
- Methods And Systems For Combinatorial Chromatin-ip SequencingMay 14, 2026 · Application 18747950Pending
- Systems And Methods To Detect Rare Mutations And Copy Number VariationMay 12, 2026 · US 12,624,400Granted
- Methods And Systems For Adjusting Tumor Mutational Burden By Tumor Fraction And CoverageMay 7, 2026 · Application 19440457Pending
- Methods For Detecting And Suppressing Alignment Errors Caused By Fusion EventsMay 7, 2026 · Application 19215195Pending
- Methylation Sequencing Through Methylation Preserving Amplification With Error CorrectionMay 7, 2026 · Application 19243171Pending
- Methods And Systems For Analyzing Nucleic Acid MoleculesMay 7, 2026 · Application 19440472Pending
Related companies, and why
- ORPHAGEN PHARMACEUTICALS, INC.Similar federal contract value in Biotech · $15K in contracts
- CHEMBIND LLCSimilar federal contract value in Biotech · $15K in contracts
- BioCardia, Inc.Similar federal contract value in Biotech · $15K in contracts
- PK BIOSCIENCES CORPORATIONSimilar federal contract value in Biotech · $14K in contracts
- Cellular Engineering Technologies, Inc.Similar federal contract value in Biotech · $14K in contracts
- MOLECULAR TRANSFER, INC.Similar federal contract value in Biotech · $13K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .